QuanMed AI | Biggest DeSci Launch

Google DeepMind just published a map of every single-letter DNA change that could occur in the human genome. All nine billion of them. Free to access. A petabyte of data. Predictions covering not just the 2% of the genome that codes for proteins, but the other 98% - the noncoding territory that medicine has largely been flying blind over for decades. That last part is the real story. The protein-coding genome gets the attention because we know how to read it. A mutation changes an amino acid, an amino acid changes a protein & the downstream logic is traceable. But the vast majority of genetic variants that influence disease sit outside that tidy 2%. They regulate gene expression, shape tissue-specific behavior, modulate timing. They matter enormously & we've had almost no systematic way to interpret them. That's not a gap at the edge of genomics. It's a gap at the center of it. AlphaGenome's AVI score - combining variant impact across both protein-coding & noncoding regions into a single number - is an attempt to collapse that interpretive distance. It's early. It's predictive, not proven. But the scale changes what becomes possible: rare diseases that have resisted diagnosis for years suddenly have a candidate mechanism worth investigating. The genome has always contained this information. We just lacked the resolution to read it. This is precisely where atomic formula building - the framework that’s at the core of Quanmed.AI’s architecture becomes relevant. Biological meaning isn't assembled at the level of the whole gene, but from the smallest verifiable relationships upward, each weighted, traced & revisable as new evidence arrives. The alphabet was always there. The AlphaGenome Atlas is finally a dictionary. https://x.com/quanmed_ai/status/2097463172923879496

𝗧𝘄𝗼 𝗣𝗵𝗮𝗿𝗺𝗮 𝗚𝗶𝗮𝗻𝘁𝘀, 𝗢𝗻𝗲 𝗕𝗿𝗼𝗸𝗲𝗻 𝗧𝗵𝗲𝘀𝗶𝘀 🔗 https://x.com/RussellQuantum/status/2098341504049721834

Maria Branyas died at 117. Scientists just finished the most detailed biological study ever done on a supercentenarian & the result breaks the model most of us carry around about aging. She was not aging slowly. Her telomeres were very short. Her immune system was inflammatory. Her B lymphocytes were old. By those markers, she was exactly as ancient as her birth certificate said. But multiple epigenetic clocks put her biological age more than 23 years below her chronological age. Her inflammation was exceptionally low. Her cholesterol profile looked protective. Her gut was rich in Bifidobacterium - the microbe that usually collapses in old age - closer to a healthy young adult than a 117-year-old. She also carried rare genetic variants clustered around four things: immune fitness, brain protection, heart protection, and mitochondrial function. The researchers' phrase for it is that aging & disease became decoupled. She aged. She just didn't get sick. That's the whole argument for personalized medicine in one woman. There is no single clock. There are dozens, running at different speeds in the same body & the only way to know which of yours are running fast is to measure them. It took a full multi-omic workup to see Branyas clearly. At QuanMed, that the resolution we are building toward for everyone else. https://x.com/quanmed_ai/status/2098832947084206516

Fission yeast just made a surprisingly strong case for your morning coffee. ☕️ Researchers at Queen Mary University of London found that caffeine activates AMPK - the cell's built-in fuel gauge, the same pathway targeted by metformin - within minutes. AMPK switches on when energy drops. It tells the cell to conserve, repair & resist stress. The catch, stated plainly: this was done in yeast. Not mice. Not humans. Yeast. Which is either humbling or quietly fascinating, depending on your disposition - because AMPK is so ancient & so conserved that a single-celled fungus runs the same sensor mammals do. Evolution kept it intact for hundreds of millions of years. Is your flat white a longevity drug? No. Most promising yeast findings don't survive the trip to humans. But it is worth asking why a cup of coffee & a diabetes drug pull the same lever & how rarely anyone measures that lever in an actual living person. That is the mitochondrial layer Quanmed AI is building around. https://x.com/quanmed_ai/status/2099495673561297111

A man with ALS just said "I love you" to his wife using a brain implant. 😢 ALS destroyed his ability to produce speech, but his brain never stopped generating the commands for it. The implant records those signals in the cortex and decodes them before they reach a body that can't carry them out. Neuralink posted the clip yesterday. The output is synthesized in a voice modeled on his own. Which reframes what the disease actually did. We describe ALS as taking speech away. It didn't. It severed the path between the intention and the muscles. The intention was intact the entire time. That's the premise personalized medicine keeps running into. What looks like absence is often signal we couldn't read yet & the treatment isn't restoring the function, it's building a new route to it. https://x.com/quanmed_ai/status/2100633582322544665

When pre sale?

@RussellQuanMed what do you think about xanadu? Partnership with amd sounds promising but a lot of negative heat around in public

A Yale study just published in Nature Communications found something worth sitting with. Fine-tuning a large language model on medical data improved diagnostic accuracy - the correct diagnosis appearing as the top prediction rose from 48.6% to 54.8%. Cardiology and nephrology improved by more than ten percentage points. Real, measurable clinical gain. Across those same 10,000 evaluated outputs, the researchers identified 3,192 instances of protected health information being reproduced from training data. The same process. One mechanism. Both outcomes at once. That's not a bug waiting for a patch. It's a design constraint, and the authors are careful to say so - memorisation isn't uniformly harmful, but reproducing sensitive clinical content from training data is a privacy exposure baked into the adaptation itself. Which means privacy architecture can't be a policy document you attach afterwards. It has to be structural, or it isn't real. This is the problem quanmed.ai has built its Lepton Lab governance regime around. Not because the solution to memorization is a better disclaimer, but because consent, provenance & de-identification have to be properties of the underlying architecture. Granular permissions the data owner can revise at any time. Clinician verification before data enters the ledger. One-way cryptographic hashing that decouples identity from the record. A blockchain topology where retrospective alteration is detectable, not merely prohibited. All of it framed within UK GDPR, the Data Protection Act 2018 & the common-law duty of confidentiality. The Yale finding isn't an argument against fine-tuning medical models. It's an argument that the data infrastructure underneath them determines what's permissible. Better models require better foundations. https://x.com/quanmed_ai/status/2104942926774116504?s=4